Otsuka Pharmaceutical Factory, Inc. clinical trials
A subsidiary of Otsuka Holdings Co., Ltd.
The registry lists 3 studies whose lead sponsor is Otsuka Pharmaceutical Factory, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Registry sponsor names on this page
- Otsuka Pharmaceutical Factory, Inc.3 studies
Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Otsuka Holdings Co., Ltd. studies →
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusRecruitingNCT06575426Phase 1/2
Sponsor listed in the registry: Otsuka Pharmaceutical Factory, Inc.
- First-in-Human Safety and Tolerability Study of OPF-110 in Healthy AdultsActive, not recruitingNCT07848334Phase 1
Sponsor listed in the registry: Otsuka Pharmaceutical Factory, Inc.
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult SubjectsCompletedNCT04838639Phase 1
Sponsor listed in the registry: Otsuka Pharmaceutical Factory, Inc.